Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states A Sulaiman, S McGarry, L Li, D Jia, S Ooi, C Addison, J Dimitroulakos, ... Molecular oncology 12 (4), 423-440, 2018 | 66 | 2018 |
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells A Sulaiman, S McGarry, KM Lam, S El-Sahli, J Chambers, S Kaczmarek, ... Cell death & disease 9 (8), 815, 2018 | 44 | 2018 |
CSCs in breast cancer—one size does not fit all: Therapeutic advances in targeting heterogeneous epithelial and mesenchymal CSCs A Sulaiman, S McGarry, X Han, S Liu, L Wang Cancers 11 (8), 1128, 2019 | 36 | 2019 |
Both bulk and cancer stem cell subpopulations in triple‐negative breast cancer are susceptible to Wnt, HDAC, and ER α coinhibition A Sulaiman, B Sulaiman, L Khouri, S McGarry, C Nessim, A Arnaout, X Li, ... FEBS letters 590 (24), 4606-4616, 2016 | 32 | 2016 |
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature S El-Sahli, K Hua, A Sulaiman, J Chambers, L Li, E Farah, S McGarry, ... Cell death & disease 12 (1), 8, 2021 | 29 | 2021 |
Co-targeting bulk tumor and CSCs in clinically translatable TNBC patient-derived xenografts via combination nanotherapy A Sulaiman, S McGarry, S El-Sahli, L Li, J Chambers, A Phan, M Cote, ... Molecular Cancer Therapeutics 18 (10), 1755-1764, 2019 | 19 | 2019 |
Targeting hypoxia sensitizes TNBC to cisplatin and promotes inhibition of both bulk and cancer stem cells A Sulaiman, S McGarry, J Chambers, E Al-Kadi, A Phan, L Li, K Mediratta, ... International Journal of Molecular Sciences 21 (16), 5788, 2020 | 15 | 2020 |
Nanoparticles Loaded with Wnt and YAP/Mevalonate Inhibitors in Combination with Paclitaxel Stop the Growth of TNBC Patient‐Derived Xenografts and Diminish Tumorigenesis A Sulaiman, S McGarry, S El‐Sahli, L Li, J Chambers, A Phan, E Al‐Kadi, ... Advanced Therapeutics 3 (11), 2000123, 2020 | 1 | 2020 |
Inhibition of Hypoxia and EGFR Sensitizes TNBC to Cisplatin and Suppresses Bulk and Cancer Stem Cells S McGarry Université d'Ottawa/University of Ottawa, 2020 | | 2020 |
PO-428 Therapeutic potential of nanoparticle encapsulated Wnt and YAP inhibitors using patient derived xenograft models for the treatment of triple negative breast cancer A Sulaiman, S Mcgarry, A Arnaout, C Nessim, S Gadde, L Wang ESMO Open 3, A190-A191, 2018 | | 2018 |